Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roni Shiloh

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Clinical Psychopharmacology|May 15, 2002
High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndromeHaggai Hermesh, Iris Manor, Roni Shiloh, et al.
The Journal of Clinical Psychiatry|March 9, 2004
Musical hallucinations: prevalence in psychotic and nonpsychotic outpatientsHaggai Hermesh, Shai Konas, Roni Shiloh, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 18, 2006
Psychological and cytokine changes in children and adolescents undergoing hematopoietic stem cell transplantationDafna Munitz-Shenkar, Tamar Krulik, Chava Peretz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 26, 2003
Alternation learning in OCD/schizophrenia patientsHaggai Hermesh, Abraham Weizman, Shai Gur, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2002
Increased corneal temperature in drug-free male schizophrenia patientsRoni Shiloh, Shirley Portuguese, Liron Bodinger, et al.
Neuropsychobiology|July 30, 2003
Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patientsRoni Shiloh, Liron Bodinger, Nachum Katz, et al.
International Clinical Psychopharmacology|April 19, 2003
Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatientsRoni Shiloh, Avi Valevski, Liron Bodinger, et al.
The Journal of Clinical Psychiatry|November 6, 2002
Sexual function and behavior in social phobiaLiron Bodinger, Haggai Hermesh, Dov Aizenberg, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 10, 2002
Serum creatine kinase levels in untreated hospitalized adolescents during acute psychosisHaggai Hermesh, Daniel Stein, Iris Manor, et al.
Clinical Neuropharmacology|November 4, 2008
Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label studyRafael Stryjer, Baruch Spivak, Rael D Strous, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Psychopharmacology|May 15, 2002
High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndromeHaggai Hermesh, Iris Manor, Roni Shiloh, et al.
The Journal of Clinical Psychiatry|March 9, 2004
Musical hallucinations: prevalence in psychotic and nonpsychotic outpatientsHaggai Hermesh, Shai Konas, Roni Shiloh, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 18, 2006
Psychological and cytokine changes in children and adolescents undergoing hematopoietic stem cell transplantationDafna Munitz-Shenkar, Tamar Krulik, Chava Peretz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 26, 2003
Alternation learning in OCD/schizophrenia patientsHaggai Hermesh, Abraham Weizman, Shai Gur, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2002
Increased corneal temperature in drug-free male schizophrenia patientsRoni Shiloh, Shirley Portuguese, Liron Bodinger, et al.
Neuropsychobiology|July 30, 2003
Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patientsRoni Shiloh, Liron Bodinger, Nachum Katz, et al.
International Clinical Psychopharmacology|April 19, 2003
Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatientsRoni Shiloh, Avi Valevski, Liron Bodinger, et al.
The Journal of Clinical Psychiatry|November 6, 2002
Sexual function and behavior in social phobiaLiron Bodinger, Haggai Hermesh, Dov Aizenberg, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 10, 2002
Serum creatine kinase levels in untreated hospitalized adolescents during acute psychosisHaggai Hermesh, Daniel Stein, Iris Manor, et al.
Clinical Neuropharmacology|November 4, 2008
Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label studyRafael Stryjer, Baruch Spivak, Rael D Strous, et al.
Pageof 3